Publications in SCI - listed Journals

1. Liang, Q. Y., Chow, A. H. L., Wang Y. T., Tong, H. H. Y., Zheng, Y. “Removal of toxic aristolochic acid components from Aristolochia plants by supercritical fluid extraction”, Separation and Purification Technology. 72: 269-274. (2010).
2. Tong, H. H. Y., Chow, A. S. F., Chan, H. M., Chow, A. H. L., Wan, Y. K. Y., Williams, I. D., Shek, F. L. Y., Chan, C. K. “Process-induced phase transformation of berberine chloride hydrates”, Journal of Pharmaceutical Sciences. 99 (4): 1942-1954. (2010).
3. Xi, J., Chang, Q., Chan , C. K., Meng, Z. Y., Wang, G. N., Sun, J. B., Wang, Y. T., Tong, H. H. Y., Zheng, Y. “Formulation development and bioavailability evaluation of a self-nanoemulsified drug delivery system of oleanolic acid”, AAPSPharmSciTech, 10 (1): 172-182 (2009).
4. Tong, H. H. Y., Wong, S. Y. S., Law, M. W. L., Chu, K. K. W. and Chow, A. H. L. “Anti-hygroscopic effect of dextrans in herbal formulations”, International Journal of Pharmaceutics, 363: 99-105 (2008).
5. Chow, K., Tong, H. H. Y., Lum, S. and Chow, A. H. L. “Engineering of pharmaceutical materials - An industrial perspective”, Journal of Pharmaceutical Sciences, 97 (8): 2855-2877 (2008).
6. Tong, H. H. Y., Wu, H. B., Zheng, Y., Xi, J., Chow, A.H.L. and Chan, C.K. “Physical characterization of oleanolic acid nonsolvate and solvates prepared by solvent recrystallization”, International Journal of Pharmaceutics, 355: 195-202(2008).
7. Tong, H. H. Y., Shekunov, B. Yu., York, P. and Chow, A. H. L. “Influence of operating temperature and pressure on the polymorphic transition of salmeterol xinafoate in supercritical fluids”, Journal of Pharmaceutical Sciences, 97 (2): 1025-1029(2008).
8. Chow, A. H. L., Tong, H. H. Y., Chattopadhyay, P. and Shekunov, B. Y. “Particle engineering for pulmonary delivery”, Pharmaceutical Research, 24 (3): 411-437 (2007).
9. Shekunov, B.Y., Chattopadhyay, P., Tong, H. H. Y., Chow, A. H. L. and Grossmann, J. G. “Structure and drug release in a crosslinked poly(ethylene oxide) hydrogel”, International Journal of Pharmaceutics, 96 (5): 1320-1330 (2007).
10. Shekunov, B. Y., Chattopadhyay, P., Tong, H. H. Y. and Chow, A. H. L. “Particle size analysis in pharmaceutics: Principles, methods and applications”, Pharmaceutical Research, 24 (2): 203-227 (2007).
11. Tong, H. H. Y., Heong, S. S. P. and Chang, S. “Investigation of the antibacterial effects of cranberry juice in urine”, American Journal of Health-System Pharmacy, 63: 1417-1419 (2006).
12. Tong, H. H. Y., Shekunov, B. Yu., York, P. and Chow, A. H. L. “Predicting the aerosol performance of dry powder inhalation formulations by interparticulate interaction analysis using inverse gas chromatography”, Journal of Pharmaceutical Sciences, 95(1): 228-233 (2006).
13. Chew, N. Y. K., Shekunov, B.Y., Tong, H. H. Y., Chow, A. H. L., Savage, C., Wu, J. and Chan, H. K. “Effect of amino acids on the dispersion of disodium cromoglycate powders”, Journal of Pharmaceutical Sciences, 94(10): 2289-2300 (2005).
14. Tong, H. H. Y., Shekunov, B. Yu., Chan, J. P., Mok, C. K. F., Hung, H. C. M. and Chow, A. H. L. “An improved thermoanalytical approach to quantifying trace levels of polymorphic impurity in drug powders”, International Journal of Pharmaceutics, 295(1-2): 191-199 (2005).
15. Tong, H. H. Y., Shekunov, B. Yu., York, P. and Chow, A. H. L. “Surface characterization of salmeterol xinafoate powders by inverse gas chromatography at finite coverage”, Journal of Pharmaceutical Sciences, 94(3): 695-700 (2005).
16. Chow, A. H. L., Tong, H. H. Y., Shekunov, B. Yu. and York, P. “Use of inverse gas chromatography (IGC) to determine the surface energy and surface area of powdered materials”, Pharmaceutical Research, 21(9): 1718-1720 (2004).
17. Tong, H. H. Y., Shekunov, B. Yu., York, P. and Chow, A. H. L. “Thermal analysis of trace level of polymorphic impurity in salmeterol xinafoate samples”, Pharmaceutical Research, 20(9): 1423-1429 (2003).
18. Shekunov, B. Yu., Feeley, J. C., Chow, A. H. L., Tong, H. H. Y. and York, P. “Aerosolisation behaviour of micronised and supercritically-processed salmeterol xinafoate”, Journal of Aerosol Sciences, 34: 553-568 (2003).
19. Tong, H. H. Y., Shekunov, B. Yu., York, P. and Chow, A. H. L. “Influence of polymorphism on the surface energetics of salmeterol xinafoate crystallized from supercritical fluids”, PharmaceuticalResearch,19(5): 640 – 648 (2002).
20. Tong, H. H. Y., Shekunov, B. Yu., York, P. and Chow, A. H. L. “Characterization of two polymorphs of salmeterol xinafoate crystallized from supercritical fluids”, Pharmaceutical Research, 18(6): 852 – 858 (2001).
21. Chow, A. H. L, Ho, S. S. S., Tong, H. H. Y. and Ma, H. H. M. “Parameters affecting in-liquid drying microencapsulation and release rate of cefaclor”, International Journal of Pharmaceutics, 172: 113 - 125 (1998).